Delaying vascular aging with chinese medicine: Implications from an overview of the p53 and miR-34s family

Ming Wang; Yan Lei

doi:10.1007/s11655-011-0823-y

Your Location：

Home >

Browse articles >

Delaying vascular aging with chinese medicine: Implications from an overview of the p53 and miR-34s family

ReviewPaper | Updated：2021-08-27

- Delaying vascular aging with chinese medicine: Implications from an overview of the p53 and miR-34s family
- Delaying vascular aging with chinese medicine: Implications from an overview of the p53 and miR-34s family
- 中国结合医学杂志（英文版） 2011年17卷第8期页码：635-639
- Affiliations：
  
  Xiyuan Hospital, China Academy of Chinese Medical Sciences,Beijing,China
- Author bio：
- Funds：
  
  Supported by National Natural Science Foundation of China (No. 30973828), Major State Basic Research Development Program of China (937 Program, No. 2007CB507400), Self-Project Foundation from China Academy of Chinese Medical Sciences (No. Z02151)
- DOI：10.1007/s11655-011-0823-y
  中图分类号：
- 纸质出版日期：2011，
  
  网络出版日期：2011-8-9，
Scan for full text
Wang, M., Lei, Y. Delaying vascular aging with chinese medicine: Implications from an overview of the p53 and miR-34s family., Chin. J. Integr. Med. 17, 635 (2011). https://doi.org/10.1007/s11655-011-0823-y

Ming Wang, Yan Lei. Delaying vascular aging with chinese medicine: Implications from an overview of the p53 and miR-34s family[J]. Chinese Journal of Integrative Medicine, 2011,17(8):635-639.
Wang, M., Lei, Y. Delaying vascular aging with chinese medicine: Implications from an overview of the p53 and miR-34s family., Chin. J. Integr. Med. 17, 635 (2011). https://doi.org/10.1007/s11655-011-0823-y DOI：

Ming Wang, Yan Lei. Delaying vascular aging with chinese medicine: Implications from an overview of the p53 and miR-34s family[J]. Chinese Journal of Integrative Medicine, 2011,17(8):635-639. DOI： 10.1007/s11655-011-0823-y.

摘要

p53 is an important target for studying vascular aging. However

as people gradually learned more about the miR-34s and the relationship between miR-34s and p53

new research idea emerged. This paper tries to elaborate the feature of p53

microRNA and miR-34s in-depth

analyze the regulatory action of miR-34s on p53

and offer some new prevention and treatment prospects about vascular aging in Chinese medicine.

Abstract

p53 is an important target for studying vascular aging. However

as people gradually learned more about the miR-34s and the relationship between miR-34s and p53

new research idea emerged. This paper tries to elaborate the feature of p53

microRNA and miR-34s in-depth

analyze the regulatory action of miR-34s on p53

and offer some new prevention and treatment prospects about vascular aging in Chinese medicine.

关键词

vascular agingp53miR-34sChinese Medicine

Keywords

vascular agingp53miR-34sChinese Medicine

references

He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007;447:1130–1134.

Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007;26:731–743.

Heiko H. p53 enters the microRNA world. Cancer Cell 2007;12:414–418.

He L, He X, Lowe SW, Hannon GJ. microRNAs join the p53 network—another piece in the tumour-suppression puzzle. Nat Rev Cancer 2007;7:819–822.

Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY. MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 2007;67:8433–8438.

Rokhlin OW, Scheinker VS, Taghiyev AF, Bumcrot D, Glover RA, Cohen MB. MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer. Cancer Biol Ther 2008;7:1288–1296.

Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007;26:745–752.

Paris R, Henry RE, Stephens SJ, McBryde M, Espinosa JM. Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation. Cell Cycle 2008;7:2427–2433.

Yamakuchi M, Lowenstein CJ. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle 2009;8:712–715.

Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007;104:15472–15477.

Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 2008;105:13421–13426.

Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends in Cell Biol 2001;11:S27–S31.

Vogelstein B, Lane D, Levine JA. Surfing the p53 network. Nature 2000;408:307–310.

Wanger M, HamPel B, Bernhard D, Hala M, Zwerschke W, Jansen-Durr P. Replicative senescence of human endothelial cells in vitro involves arrest: polyploization and senescence—associated apoptosis. Exp Gerontol 2001;36:1327–1347.

Wahl GM, Carr AM. The evolution of diverse biological responses to DNA dam age: insights from yeast and p53. Nat Cell Biol 2001;3:E277–E286.

Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21CIP1, but not p16INK4a. Mol Cell 2004;14:501–513.

Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 2000;406:207–210.

Kunieda T, Minamino T, Nishi J, Tateno K, Oyama T, Katsuno T, et al. Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation 2 2006;114:953–960.

Chen RX, Ye SL. MicroRNAs and tumor. Internat J Surg (Chin) 2007;34:171–173.

Gao JL, Luo YP, Li SG. Molecular evolution of miR-34 gene family. Zoological Res 2007;28:271–278.

He X, He L, Hannon GJ. The guardian’s little helper: microRNAs in the p53 tumor suppressor network. Cancer Res 2007;67:11099–11101.

Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007;6:1586–1593.

Kumamoto K, Spillare EA, Fujita K, Horikawa I, Yamashita T, Appella E, et al. Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence. Cancer Res 2008;68:3193–3203.

Welch C, Chen Y, Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007;26:5017–5022.

Yan DS, Zhou XT, Chen XY, Hu DN, Dong XD, Wang J, et al. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest Ophthalmol Vis Sci 2009;50:1559–1565.

Christoffersen NR, Shalgi R, Frankel LB, Leucci E, Lees M, Klausen M, et al. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ 2009;17:236–24

Maes OC, An J, Sarojini H, Wang E. Murine microRNAs implicated in liver functions and aging process. Mech Ageing Dev 2008;129:534–541.

Lafferty-Whyte K, Cairney CJ, Jamieson NB, Oiena KA, Keith WN. Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms. Biochim Biophys Acta 2009;1792:341–352.

Salminen A, Kaarniranta K. SIRT1: regulation of longevity via autophagy. Cell Signal 2009;21:1356–1360.

Salminen A, Kaarniranta K. Regulation of the aging process by autophagy. Trends Mol Med 2009;15:217–224.

Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007;17:1298–1307.

Qi RZ, An HZ, Yu YZ, Zhang MH, Liu SX, Xu HM, et al. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res 2003;63:8323–8329.

Timmers C, Sharma N, Opavsky R, Maiti B, Wu LZ, Wu J, et al. E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop. Mol Cell Biol 2007;27:65–78.

Wu LZ, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, et al. The E2F1–3 transcription factors are essential for cellular proliferation. Nature 2001;414:457–462.

Sharma N, Timmers C, Trikha P, Saavedra HI, Obery A, Leone G. Control of the p53-p21CIP1 Axis by E2f1, E2f2, and E2f3 is essential for G1/S progression and cellular transformation. J Biol Chem 2006;281:36124–36131.

Yang J, Lei Y. Progress on research of the relationship between cell aging and aging of blood vessels. Chin J Intergr West Med (Chin) 2009;29:369–374.

Yang J, Lei Y, Cui W, Fang SP, Chen KJ. Study on acting mechanism of extracts from Ginseng, Notoglnseng and Chuanxiong from delaying the aging of endothelial cells. China J Chin Mater Med (Chin) 2009;34:1544–1547.

FULL TEXT LINK

More>

浏览量

821

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Atherosclerosis, vascular aging and therapeutic strategies

Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture

Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients

Objective tongue inspection on 142 liver cancer patients with damp-heat syndrome

Effect of Ermiao Recipe (二妙方) with medicinal guide Angelicae Pubescentis Radix on promoting the homing of bone marrow stem cells to treat cartilage damage in osteoarthritis rats